PHIO
PHIO
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
2
$17K
Insider Sales
0
$0
Total Volume
$17K
2 transactions
Net Activity
+$17K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Plott Ronald Todd
Dir
$10K total
Bradford Patricia A
Dir
$7K total
Quick Actions
PHIO has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at PHIO (PHIO) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $17K.
The net insider activity for PHIO shows a net buying bias of $17K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Plott Ronald Todd (Dir), who traded 10.0K shares valued at $10K on Sep 28, 2026.
Phio Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard
IDAI,AMRC,NTHI,PRTS,LIEN,AGMB,RGCO,LRMR,SELF,AN,AIAI,REFI,EQPT,MTDR,GROV,BRID,AFCG,DTI,SRTS,BGDE,WVVI,PHIO,PAM,GME | Stock Prices | Quote Comparison - Yahoo Finance
Form 8K Phio Pharmaceuticals Corp For: 20 November By Investing.com
Phio Pharmaceuticals (PHIO) director Deming bought 12,000 shares for $9,823 at an average $0.82
PHIO - Phio Pharmaceuticals Corp Stock Price and Quote
Director David H. Deming buys Phio Pharmaceuticals (PHIO) shares in two purchases.
FAQs About PHIO Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for PHIO.